Global Peptide Vaccine Supply, Demand and Key Producers, 2023-2029

Description

The global Peptide Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Peptide vaccines include one or more short or long amino acids sequences, as an antigen combined with a vaccine adjuvant. Thus they fall in the broad category of defined antigen vaccines, along with the vaccines using proteins, protein sub units, DNA and RNA. They remain the most immunogenic approaches based on the measures of T-cell responses. Peptide immunogenicity is influenced by the way in which peptides are presented to the immune system, underscoring the need for multifunctional delivery systems that couple antigen and adjuvant into a single construct.

This report studies the global Peptide Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Peptide Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Peptide Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Peptide Vaccine total production and demand, 2018-2029, (K Dose)
Global Peptide Vaccine total production value, 2018-2029, (USD Million)
Global Peptide Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Dose)
Global Peptide Vaccine consumption by region & country, CAGR, 2018-2029 & (K Dose)
U.S. VS China: Peptide Vaccine domestic production, consumption, key domestic manufacturers and share
Global Peptide Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Dose)
Global Peptide Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Dose)
Global Peptide Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Dose)
This reports profiles key players in the global Peptide Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Anergis, Antigen Express, Apitope Technology, Artificial Cell Technologies, Benovus Bio, Celgene Corporation, Immatics biotechnologies, Merck and ImmunoCellular Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Peptide Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Peptide Vaccine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Peptide Vaccine Market, Segmentation by Type
    Solution Phase Synthesis (SPS)
    Solid Phase Peptide Synthesis (SPPS)

Global Peptide Vaccine Market, Segmentation by Application
    Prostate Cancer
    Breast Cancer
    Gastric Cancer
    Lung Cancer
    Pancreatic Cancer
    Others

Companies Profiled:
    Anergis
    Antigen Express
    Apitope Technology
    Artificial Cell Technologies
    Benovus Bio
    Celgene Corporation
    Immatics biotechnologies
    Merck
    ImmunoCellular Therapeutics
    ISA Pharmaceuticals
    Lytix Biopharma
    Spotlight Innovation
    OncoTherapy Science
    Peptech
    Pharmasyntez
    Sumitomo Dainippon Pharma
    TapImmune
    Targovax

Key Questions Answered
1. How big is the global Peptide Vaccine market?
2. What is the demand of the global Peptide Vaccine market?
3. What is the year over year growth of the global Peptide Vaccine market?
4. What is the production and production value of the global Peptide Vaccine market?
5. Who are the key producers in the global Peptide Vaccine market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Peptide Vaccine Introduction
    1.2 World Peptide Vaccine Supply & Forecast
        1.2.1 World Peptide Vaccine Production Value (2018 & 2022 & 2029)
        1.2.2 World Peptide Vaccine Production (2018-2029)
        1.2.3 World Peptide Vaccine Pricing Trends (2018-2029)
    1.3 World Peptide Vaccine Production by Region (Based on Production Site)
        1.3.1 World Peptide Vaccine Production Value by Region (2018-2029)
        1.3.2 World Peptide Vaccine Production by Region (2018-2029)
        1.3.3 World Peptide Vaccine Average Price by Region (2018-2029)
        1.3.4 North America Peptide Vaccine Production (2018-2029)
        1.3.5 Europe Peptide Vaccine Production (2018-2029)
        1.3.6 China Peptide Vaccine Production (2018-2029)
        1.3.7 Japan Peptide Vaccine Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Peptide Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Peptide Vaccine Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Peptide Vaccine Demand (2018-2029)
    2.2 World Peptide Vaccine Consumption by Region
        2.2.1 World Peptide Vaccine Consumption by Region (2018-2023)
        2.2.2 World Peptide Vaccine Consumption Forecast by Region (2024-2029)
    2.3 United States Peptide Vaccine Consumption (2018-2029)
    2.4 China Peptide Vaccine Consumption (2018-2029)
    2.5 Europe Peptide Vaccine Consumption (2018-2029)
    2.6 Japan Peptide Vaccine Consumption (2018-2029)
    2.7 South Korea Peptide Vaccine Consumption (2018-2029)
    2.8 ASEAN Peptide Vaccine Consumption (2018-2029)
    2.9 India Peptide Vaccine Consumption (2018-2029)

3 World Peptide Vaccine Manufacturers Competitive Analysis
    3.1 World Peptide Vaccine Production Value by Manufacturer (2018-2023)
    3.2 World Peptide Vaccine Production by Manufacturer (2018-2023)
    3.3 World Peptide Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Peptide Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Peptide Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Peptide Vaccine in 2022
        3.5.3 Global Concentration Ratios (CR8) for Peptide Vaccine in 2022
    3.6 Peptide Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Peptide Vaccine Market: Region Footprint
        3.6.2 Peptide Vaccine Market: Company Product Type Footprint
        3.6.3 Peptide Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Peptide Vaccine Production Value Comparison
        4.1.1 United States VS China: Peptide Vaccine Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Peptide Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Peptide Vaccine Production Comparison
        4.2.1 United States VS China: Peptide Vaccine Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Peptide Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Peptide Vaccine Consumption Comparison
        4.3.1 United States VS China: Peptide Vaccine Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Peptide Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Peptide Vaccine Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Peptide Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Peptide Vaccine Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Peptide Vaccine Production (2018-2023)
    4.5 China Based Peptide Vaccine Manufacturers and Market Share
        4.5.1 China Based Peptide Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Peptide Vaccine Production Value (2018-2023)
        4.5.3 China Based Manufacturers Peptide Vaccine Production (2018-2023)
    4.6 Rest of World Based Peptide Vaccine Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Peptide Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Peptide Vaccine Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Peptide Vaccine Production (2018-2023)

5 Market Analysis by Type
    5.1 World Peptide Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Solution Phase Synthesis (SPS)
        5.2.2 Solid Phase Peptide Synthesis (SPPS)
    5.3 Market Segment by Type
        5.3.1 World Peptide Vaccine Production by Type (2018-2029)
        5.3.2 World Peptide Vaccine Production Value by Type (2018-2029)
        5.3.3 World Peptide Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Peptide Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Prostate Cancer
        6.2.2 Breast Cancer
        6.2.3 Gastric Cancer
        6.2.4 Lung Cancer
        6.2.5 Pancreatic Cancer
        6.2.6 Others
    6.3 Market Segment by Application
        6.3.1 World Peptide Vaccine Production by Application (2018-2029)
        6.3.2 World Peptide Vaccine Production Value by Application (2018-2029)
        6.3.3 World Peptide Vaccine Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Anergis
        7.1.1 Anergis Details
        7.1.2 Anergis Major Business
        7.1.3 Anergis Peptide Vaccine Product and Services
        7.1.4 Anergis Peptide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Anergis Recent Developments/Updates
        7.1.6 Anergis Competitive Strengths & Weaknesses
    7.2 Antigen Express
        7.2.1 Antigen Express Details
        7.2.2 Antigen Express Major Business
        7.2.3 Antigen Express Peptide Vaccine Product and Services
        7.2.4 Antigen Express Peptide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Antigen Express Recent Developments/Updates
        7.2.6 Antigen Express Competitive Strengths & Weaknesses
    7.3 Apitope Technology
        7.3.1 Apitope Technology Details
        7.3.2 Apitope Technology Major Business
        7.3.3 Apitope Technology Peptide Vaccine Product and Services
        7.3.4 Apitope Technology Peptide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Apitope Technology Recent Developments/Updates
        7.3.6 Apitope Technology Competitive Strengths & Weaknesses
    7.4 Artificial Cell Technologies
        7.4.1 Artificial Cell Technologies Details
        7.4.2 Artificial Cell Technologies Major Business
        7.4.3 Artificial Cell Technologies Peptide Vaccine Product and Services
        7.4.4 Artificial Cell Technologies Peptide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Artificial Cell Technologies Recent Developments/Updates
        7.4.6 Artificial Cell Technologies Competitive Strengths & Weaknesses
    7.5 Benovus Bio
        7.5.1 Benovus Bio Details
        7.5.2 Benovus Bio Major Business
        7.5.3 Benovus Bio Peptide Vaccine Product and Services
        7.5.4 Benovus Bio Peptide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Benovus Bio Recent Developments/Updates
        7.5.6 Benovus Bio Competitive Strengths & Weaknesses
    7.6 Celgene Corporation
        7.6.1 Celgene Corporation Details
        7.6.2 Celgene Corporation Major Business
        7.6.3 Celgene Corporation Peptide Vaccine Product and Services
        7.6.4 Celgene Corporation Peptide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Celgene Corporation Recent Developments/Updates
        7.6.6 Celgene Corporation Competitive Strengths & Weaknesses
    7.7 Immatics biotechnologies
        7.7.1 Immatics biotechnologies Details
        7.7.2 Immatics biotechnologies Major Business
        7.7.3 Immatics biotechnologies Peptide Vaccine Product and Services
        7.7.4 Immatics biotechnologies Peptide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Immatics biotechnologies Recent Developments/Updates
        7.7.6 Immatics biotechnologies Competitive Strengths & Weaknesses
    7.8 Merck
        7.8.1 Merck Details
        7.8.2 Merck Major Business
        7.8.3 Merck Peptide Vaccine Product and Services
        7.8.4 Merck Peptide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Merck Recent Developments/Updates
        7.8.6 Merck Competitive Strengths & Weaknesses
    7.9 ImmunoCellular Therapeutics
        7.9.1 ImmunoCellular Therapeutics Details
        7.9.2 ImmunoCellular Therapeutics Major Business
        7.9.3 ImmunoCellular Therapeutics Peptide Vaccine Product and Services
        7.9.4 ImmunoCellular Therapeutics Peptide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 ImmunoCellular Therapeutics Recent Developments/Updates
        7.9.6 ImmunoCellular Therapeutics Competitive Strengths & Weaknesses
    7.10 ISA Pharmaceuticals
        7.10.1 ISA Pharmaceuticals Details
        7.10.2 ISA Pharmaceuticals Major Business
        7.10.3 ISA Pharmaceuticals Peptide Vaccine Product and Services
        7.10.4 ISA Pharmaceuticals Peptide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 ISA Pharmaceuticals Recent Developments/Updates
        7.10.6 ISA Pharmaceuticals Competitive Strengths & Weaknesses
    7.11 Lytix Biopharma
        7.11.1 Lytix Biopharma Details
        7.11.2 Lytix Biopharma Major Business
        7.11.3 Lytix Biopharma Peptide Vaccine Product and Services
        7.11.4 Lytix Biopharma Peptide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Lytix Biopharma Recent Developments/Updates
        7.11.6 Lytix Biopharma Competitive Strengths & Weaknesses
    7.12 Spotlight Innovation
        7.12.1 Spotlight Innovation Details
        7.12.2 Spotlight Innovation Major Business
        7.12.3 Spotlight Innovation Peptide Vaccine Product and Services
        7.12.4 Spotlight Innovation Peptide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Spotlight Innovation Recent Developments/Updates
        7.12.6 Spotlight Innovation Competitive Strengths & Weaknesses
    7.13 OncoTherapy Science
        7.13.1 OncoTherapy Science Details
        7.13.2 OncoTherapy Science Major Business
        7.13.3 OncoTherapy Science Peptide Vaccine Product and Services
        7.13.4 OncoTherapy Science Peptide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 OncoTherapy Science Recent Developments/Updates
        7.13.6 OncoTherapy Science Competitive Strengths & Weaknesses
    7.14 Peptech
        7.14.1 Peptech Details
        7.14.2 Peptech Major Business
        7.14.3 Peptech Peptide Vaccine Product and Services
        7.14.4 Peptech Peptide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 Peptech Recent Developments/Updates
        7.14.6 Peptech Competitive Strengths & Weaknesses
    7.15 Pharmasyntez
        7.15.1 Pharmasyntez Details
        7.15.2 Pharmasyntez Major Business
        7.15.3 Pharmasyntez Peptide Vaccine Product and Services
        7.15.4 Pharmasyntez Peptide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.15.5 Pharmasyntez Recent Developments/Updates
        7.15.6 Pharmasyntez Competitive Strengths & Weaknesses
    7.16 Sumitomo Dainippon Pharma
        7.16.1 Sumitomo Dainippon Pharma Details
        7.16.2 Sumitomo Dainippon Pharma Major Business
        7.16.3 Sumitomo Dainippon Pharma Peptide Vaccine Product and Services
        7.16.4 Sumitomo Dainippon Pharma Peptide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.16.5 Sumitomo Dainippon Pharma Recent Developments/Updates
        7.16.6 Sumitomo Dainippon Pharma Competitive Strengths & Weaknesses
    7.17 TapImmune
        7.17.1 TapImmune Details
        7.17.2 TapImmune Major Business
        7.17.3 TapImmune Peptide Vaccine Product and Services
        7.17.4 TapImmune Peptide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.17.5 TapImmune Recent Developments/Updates
        7.17.6 TapImmune Competitive Strengths & Weaknesses
    7.18 Targovax
        7.18.1 Targovax Details
        7.18.2 Targovax Major Business
        7.18.3 Targovax Peptide Vaccine Product and Services
        7.18.4 Targovax Peptide Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.18.5 Targovax Recent Developments/Updates
        7.18.6 Targovax Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Peptide Vaccine Industry Chain
    8.2 Peptide Vaccine Upstream Analysis
        8.2.1 Peptide Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Peptide Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Peptide Vaccine Production Mode
    8.6 Peptide Vaccine Procurement Model
    8.7 Peptide Vaccine Industry Sales Model and Sales Channels
        8.7.1 Peptide Vaccine Sales Model
        8.7.2 Peptide Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Peptide Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Peptide Vaccine Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Peptide Vaccine Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Peptide Vaccine Production Value Market Share by Region (2018-2023)
    Table 5. World Peptide Vaccine Production Value Market Share by Region (2024-2029)
    Table 6. World Peptide Vaccine Production by Region (2018-2023) & (K Dose)
    Table 7. World Peptide Vaccine Production by Region (2024-2029) & (K Dose)
    Table 8. World Peptide Vaccine Production Market Share by Region (2018-2023)
    Table 9. World Peptide Vaccine Production Market Share by Region (2024-2029)
    Table 10. World Peptide Vaccine Average Price by Region (2018-2023) & (US$/Dose)
    Table 11. World Peptide Vaccine Average Price by Region (2024-2029) & (US$/Dose)
    Table 12. Peptide Vaccine Major Market Trends
    Table 13. World Peptide Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Dose)
    Table 14. World Peptide Vaccine Consumption by Region (2018-2023) & (K Dose)
    Table 15. World Peptide Vaccine Consumption Forecast by Region (2024-2029) & (K Dose)
    Table 16. World Peptide Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Peptide Vaccine Producers in 2022
    Table 18. World Peptide Vaccine Production by Manufacturer (2018-2023) & (K Dose)
    Table 19. Production Market Share of Key Peptide Vaccine Producers in 2022
    Table 20. World Peptide Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
    Table 21. Global Peptide Vaccine Company Evaluation Quadrant
    Table 22. World Peptide Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Peptide Vaccine Production Site of Key Manufacturer
    Table 24. Peptide Vaccine Market: Company Product Type Footprint
    Table 25. Peptide Vaccine Market: Company Product Application Footprint
    Table 26. Peptide Vaccine Competitive Factors
    Table 27. Peptide Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Peptide Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Peptide Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Peptide Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Dose)
    Table 31. United States VS China Peptide Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Dose)
    Table 32. United States Based Peptide Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Peptide Vaccine Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Peptide Vaccine Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Peptide Vaccine Production (2018-2023) & (K Dose)
    Table 36. United States Based Manufacturers Peptide Vaccine Production Market Share (2018-2023)
    Table 37. China Based Peptide Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Peptide Vaccine Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Peptide Vaccine Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Peptide Vaccine Production (2018-2023) & (K Dose)
    Table 41. China Based Manufacturers Peptide Vaccine Production Market Share (2018-2023)
    Table 42. Rest of World Based Peptide Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Peptide Vaccine Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Peptide Vaccine Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Peptide Vaccine Production (2018-2023) & (K Dose)
    Table 46. Rest of World Based Manufacturers Peptide Vaccine Production Market Share (2018-2023)
    Table 47. World Peptide Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Peptide Vaccine Production by Type (2018-2023) & (K Dose)
    Table 49. World Peptide Vaccine Production by Type (2024-2029) & (K Dose)
    Table 50. World Peptide Vaccine Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Peptide Vaccine Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Peptide Vaccine Average Price by Type (2018-2023) & (US$/Dose)
    Table 53. World Peptide Vaccine Average Price by Type (2024-2029) & (US$/Dose)
    Table 54. World Peptide Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Peptide Vaccine Production by Application (2018-2023) & (K Dose)
    Table 56. World Peptide Vaccine Production by Application (2024-2029) & (K Dose)
    Table 57. World Peptide Vaccine Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Peptide Vaccine Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Peptide Vaccine Average Price by Application (2018-2023) & (US$/Dose)
    Table 60. World Peptide Vaccine Average Price by Application (2024-2029) & (US$/Dose)
    Table 61. Anergis Basic Information, Manufacturing Base and Competitors
    Table 62. Anergis Major Business
    Table 63. Anergis Peptide Vaccine Product and Services
    Table 64. Anergis Peptide Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Anergis Recent Developments/Updates
    Table 66. Anergis Competitive Strengths & Weaknesses
    Table 67. Antigen Express Basic Information, Manufacturing Base and Competitors
    Table 68. Antigen Express Major Business
    Table 69. Antigen Express Peptide Vaccine Product and Services
    Table 70. Antigen Express Peptide Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Antigen Express Recent Developments/Updates
    Table 72. Antigen Express Competitive Strengths & Weaknesses
    Table 73. Apitope Technology Basic Information, Manufacturing Base and Competitors
    Table 74. Apitope Technology Major Business
    Table 75. Apitope Technology Peptide Vaccine Product and Services
    Table 76. Apitope Technology Peptide Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Apitope Technology Recent Developments/Updates
    Table 78. Apitope Technology Competitive Strengths & Weaknesses
    Table 79. Artificial Cell Technologies Basic Information, Manufacturing Base and Competitors
    Table 80. Artificial Cell Technologies Major Business
    Table 81. Artificial Cell Technologies Peptide Vaccine Product and Services
    Table 82. Artificial Cell Technologies Peptide Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Artificial Cell Technologies Recent Developments/Updates
    Table 84. Artificial Cell Technologies Competitive Strengths & Weaknesses
    Table 85. Benovus Bio Basic Information, Manufacturing Base and Competitors
    Table 86. Benovus Bio Major Business
    Table 87. Benovus Bio Peptide Vaccine Product and Services
    Table 88. Benovus Bio Peptide Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Benovus Bio Recent Developments/Updates
    Table 90. Benovus Bio Competitive Strengths & Weaknesses
    Table 91. Celgene Corporation Basic Information, Manufacturing Base and Competitors
    Table 92. Celgene Corporation Major Business
    Table 93. Celgene Corporation Peptide Vaccine Product and Services
    Table 94. Celgene Corporation Peptide Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Celgene Corporation Recent Developments/Updates
    Table 96. Celgene Corporation Competitive Strengths & Weaknesses
    Table 97. Immatics biotechnologies Basic Information, Manufacturing Base and Competitors
    Table 98. Immatics biotechnologies Major Business
    Table 99. Immatics biotechnologies Peptide Vaccine Product and Services
    Table 100. Immatics biotechnologies Peptide Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Immatics biotechnologies Recent Developments/Updates
    Table 102. Immatics biotechnologies Competitive Strengths & Weaknesses
    Table 103. Merck Basic Information, Manufacturing Base and Competitors
    Table 104. Merck Major Business
    Table 105. Merck Peptide Vaccine Product and Services
    Table 106. Merck Peptide Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Merck Recent Developments/Updates
    Table 108. Merck Competitive Strengths & Weaknesses
    Table 109. ImmunoCellular Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 110. ImmunoCellular Therapeutics Major Business
    Table 111. ImmunoCellular Therapeutics Peptide Vaccine Product and Services
    Table 112. ImmunoCellular Therapeutics Peptide Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. ImmunoCellular Therapeutics Recent Developments/Updates
    Table 114. ImmunoCellular Therapeutics Competitive Strengths & Weaknesses
    Table 115. ISA Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 116. ISA Pharmaceuticals Major Business
    Table 117. ISA Pharmaceuticals Peptide Vaccine Product and Services
    Table 118. ISA Pharmaceuticals Peptide Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. ISA Pharmaceuticals Recent Developments/Updates
    Table 120. ISA Pharmaceuticals Competitive Strengths & Weaknesses
    Table 121. Lytix Biopharma Basic Information, Manufacturing Base and Competitors
    Table 122. Lytix Biopharma Major Business
    Table 123. Lytix Biopharma Peptide Vaccine Product and Services
    Table 124. Lytix Biopharma Peptide Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Lytix Biopharma Recent Developments/Updates
    Table 126. Lytix Biopharma Competitive Strengths & Weaknesses
    Table 127. Spotlight Innovation Basic Information, Manufacturing Base and Competitors
    Table 128. Spotlight Innovation Major Business
    Table 129. Spotlight Innovation Peptide Vaccine Product and Services
    Table 130. Spotlight Innovation Peptide Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Spotlight Innovation Recent Developments/Updates
    Table 132. Spotlight Innovation Competitive Strengths & Weaknesses
    Table 133. OncoTherapy Science Basic Information, Manufacturing Base and Competitors
    Table 134. OncoTherapy Science Major Business
    Table 135. OncoTherapy Science Peptide Vaccine Product and Services
    Table 136. OncoTherapy Science Peptide Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. OncoTherapy Science Recent Developments/Updates
    Table 138. OncoTherapy Science Competitive Strengths & Weaknesses
    Table 139. Peptech Basic Information, Manufacturing Base and Competitors
    Table 140. Peptech Major Business
    Table 141. Peptech Peptide Vaccine Product and Services
    Table 142. Peptech Peptide Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 143. Peptech Recent Developments/Updates
    Table 144. Peptech Competitive Strengths & Weaknesses
    Table 145. Pharmasyntez Basic Information, Manufacturing Base and Competitors
    Table 146. Pharmasyntez Major Business
    Table 147. Pharmasyntez Peptide Vaccine Product and Services
    Table 148. Pharmasyntez Peptide Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 149. Pharmasyntez Recent Developments/Updates
    Table 150. Pharmasyntez Competitive Strengths & Weaknesses
    Table 151. Sumitomo Dainippon Pharma Basic Information, Manufacturing Base and Competitors
    Table 152. Sumitomo Dainippon Pharma Major Business
    Table 153. Sumitomo Dainippon Pharma Peptide Vaccine Product and Services
    Table 154. Sumitomo Dainippon Pharma Peptide Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 155. Sumitomo Dainippon Pharma Recent Developments/Updates
    Table 156. Sumitomo Dainippon Pharma Competitive Strengths & Weaknesses
    Table 157. TapImmune Basic Information, Manufacturing Base and Competitors
    Table 158. TapImmune Major Business
    Table 159. TapImmune Peptide Vaccine Product and Services
    Table 160. TapImmune Peptide Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 161. TapImmune Recent Developments/Updates
    Table 162. Targovax Basic Information, Manufacturing Base and Competitors
    Table 163. Targovax Major Business
    Table 164. Targovax Peptide Vaccine Product and Services
    Table 165. Targovax Peptide Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 166. Global Key Players of Peptide Vaccine Upstream (Raw Materials)
    Table 167. Peptide Vaccine Typical Customers
    Table 168. Peptide Vaccine Typical Distributors
List of Figure
    Figure 1. Peptide Vaccine Picture
    Figure 2. World Peptide Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Peptide Vaccine Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Peptide Vaccine Production (2018-2029) & (K Dose)
    Figure 5. World Peptide Vaccine Average Price (2018-2029) & (US$/Dose)
    Figure 6. World Peptide Vaccine Production Value Market Share by Region (2018-2029)
    Figure 7. World Peptide Vaccine Production Market Share by Region (2018-2029)
    Figure 8. North America Peptide Vaccine Production (2018-2029) & (K Dose)
    Figure 9. Europe Peptide Vaccine Production (2018-2029) & (K Dose)
    Figure 10. China Peptide Vaccine Production (2018-2029) & (K Dose)
    Figure 11. Japan Peptide Vaccine Production (2018-2029) & (K Dose)
    Figure 12. Peptide Vaccine Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Peptide Vaccine Consumption (2018-2029) & (K Dose)
    Figure 15. World Peptide Vaccine Consumption Market Share by Region (2018-2029)
    Figure 16. United States Peptide Vaccine Consumption (2018-2029) & (K Dose)
    Figure 17. China Peptide Vaccine Consumption (2018-2029) & (K Dose)
    Figure 18. Europe Peptide Vaccine Consumption (2018-2029) & (K Dose)
    Figure 19. Japan Peptide Vaccine Consumption (2018-2029) & (K Dose)
    Figure 20. South Korea Peptide Vaccine Consumption (2018-2029) & (K Dose)
    Figure 21. ASEAN Peptide Vaccine Consumption (2018-2029) & (K Dose)
    Figure 22. India Peptide Vaccine Consumption (2018-2029) & (K Dose)
    Figure 23. Producer Shipments of Peptide Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Peptide Vaccine Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Peptide Vaccine Markets in 2022
    Figure 26. United States VS China: Peptide Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Peptide Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Peptide Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Peptide Vaccine Production Market Share 2022
    Figure 30. China Based Manufacturers Peptide Vaccine Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Peptide Vaccine Production Market Share 2022
    Figure 32. World Peptide Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Peptide Vaccine Production Value Market Share by Type in 2022
    Figure 34. Solution Phase Synthesis (SPS)
    Figure 35. Solid Phase Peptide Synthesis (SPPS)
    Figure 36. World Peptide Vaccine Production Market Share by Type (2018-2029)
    Figure 37. World Peptide Vaccine Production Value Market Share by Type (2018-2029)
    Figure 38. World Peptide Vaccine Average Price by Type (2018-2029) & (US$/Dose)
    Figure 39. World Peptide Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Peptide Vaccine Production Value Market Share by Application in 2022
    Figure 41. Prostate Cancer
    Figure 42. Breast Cancer
    Figure 43. Gastric Cancer
    Figure 44. Lung Cancer
    Figure 45. Pancreatic Cancer
    Figure 46. Others
    Figure 47. World Peptide Vaccine Production Market Share by Application (2018-2029)
    Figure 48. World Peptide Vaccine Production Value Market Share by Application (2018-2029)
    Figure 49. World Peptide Vaccine Average Price by Application (2018-2029) & (US$/Dose)
    Figure 50. Peptide Vaccine Industry Chain
    Figure 51. Peptide Vaccine Procurement Model
    Figure 52. Peptide Vaccine Sales Model
    Figure 53. Peptide Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 54. Methodology
    Figure 55. Research Process and Data Source

Companies Mentioned

Anergis
Antigen Express
Apitope Technology
Artificial Cell Technologies
Benovus Bio
Celgene Corporation
Immatics biotechnologies
Merck
ImmunoCellular Therapeutics
ISA Pharmaceuticals
Lytix Biopharma
Spotlight Innovation
OncoTherapy Science
Peptech
Pharmasyntez
Sumitomo Dainippon Pharma
TapImmune
Targovax